Analyst Ratings for Rhythm Pharmaceuticals (RYTM)
RYTM Rating Summary
RYTM Price Target Summary
- Highest: $160.00 (Citizens)
- Lowest: $120.00 (Deutsche Bank)
- Average: $139.47
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$139.47 (+61.9%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
Rating Score: 9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | William Blair | Alethia Young | New Coverage | Outperform (N/A) |
N/A (N/A) |
86.71 (86.17) |
-0.62% | Details |
| 9/14/2026 | Leerink | N/A | New Coverage | Outperform (N/A) |
133.00 (N/A) |
104.71 (86.17) |
-17.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
